Jim O’Neill Is “Free For Global AMR Role” After Leaving UK Government
Executive Summary
Having suddenly resigned from the UK government, Jim O’Neill says he’s now available to take on a global role, if asked, to promote concrete action on tackling antimicrobial resistance within promised timeframes.
You may also be interested in...
UK R&D Centre for Antimicrobial Resistance Goes Into Battle
The UK's recently launched AMR Centre has launched two R&D collaborations and plans two more this year.
13 Pharmas Sign Roadmap For Antibiotic Reform – But What Do They Want?
More than 13 global pharma companies, including GlaxoSmithKline, Pfizer and Merck & Co., have agreed a "Roadmap" aimed at relieving the growing antimicrobial resistance crisis worldwide – as well as principles to explore alternative business models and incentives for antibiotic R&D and reimbursement.
UN Countries Make Bold Pledges On AMR, Including Funding For R&D Into New Drugs and Diagnostics
During the high-level UN meeting on Sept. 21, all 193 member countries will sign a declaration in which they pledge to take concrete action on tackling antimicrobial resistance, including providing resources for research into new drugs, vaccines and diagnostics, and ensuring good stewardship of antibiotic use in both humans and animals.